ArticleHarm reduction journal2025
Differences in respiratory wheezing between current exclusive e-cigarette users, current exclusive cigarette smokers, and never users of either product: findings from a population-based study.
Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- E-cigarette use among individuals with chronic obstructive pulmonary disease.Internal and emergency medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundE-cigarettes have emerged as an alternative to combustible cigarettes, yet their comparative impact on respiratory symptoms remains uncertain. We investigated cross-sectional differences in self-reported wheezing between current exclusive e-cigarette users, current exclusive cigarette smokers, and never-users of either product.
methodsWe analysed data from 9000 adults aged ≥ 16 years in the 2017-2019 Scottish Health Survey. The exposure was current nicotine use status (exclusive cigarette smoking, exclusive e-cigarette use, or never-use), and the outcome was self-reported wheezing in the past 12 months. Binary multivariable logistic regression estimated adjusted odds ratios (ORs) with 95% confidence intervals (CIs), controlling for age, sex, area-level socioeconomic deprivation, longstanding illness, doctor-diagnosed asthma and COPD, self-rated general health, alcohol consumption, age of smoking initiation, and exposure to second-hand smoke.
resultsCompared to exclusive e-cigarette users, exclusive cigarette smokers had significantly higher odds of wheezing (adjusted OR = 1.80, 95% CI: 1.33-2.42, p < 0.001). Never-users had lower odds of wheezing than exclusive e-cigarette users, though the difference was not significant (adjusted OR = 0.66, 95% CI: 0.31-1.40, p = 0.275). Among exclusive cigarette smokers, the odds of wheezing increased with smoking intensity relative to exclusive e-cigarette users, indicating a dose-response relationship (χ² = 5.91, p = 0.018). Specifically, light smokers (< 10 cigarettes/day) had elevated but not significant odds (adjusted OR = 1.32, 95% CI: 0.92-1.89, p = 0.133), while moderate smokers (10-19 cigarettes/day) showed higher odds (adjusted OR = 1.85, 95% CI: 1.33-2.59, p < 0.001), and heavy smokers (≥ 20 cigarettes/day) had the greatest odds (adjusted OR = 2.27, 95% CI: 1.57-3.28, p < 0.001). Adjusted predicted probabilities of wheezing mirrored this pattern: compared with exclusive e-cigarette users, probabilities were significantly higher for moderate smokers (+ 7.2%, p = 0.002) and heavy smokers (+ 10.0%, p < 0.001), but not for light smokers (+ 3.0%, p = 0.152) or never-users (-3.9%, p = 0.306).
conclusionsExclusive e-cigarette use was not associated with higher odds of wheezing compared with never-use, and it was linked to substantially lower odds than exclusive cigarette smoking. These findings suggest that, while complete abstinence remains the lowest-risk option, e-cigarette use may pose fewer respiratory symptoms than smoking, particularly for moderate-to-heavy smokers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.